+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluorine-18"

From
Nuclear Medicine Radioisotopes Market 2025-2033 - Product Thumbnail Image

Nuclear Medicine Radioisotopes Market 2025-2033

  • Report
  • March 2025
  • 144 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Thumbnail Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • April 2025
  • 307 Pages
  • Global
From
From
Nuclear Medicine Radioisotopes Market Report 2025 - Product Thumbnail Image

Nuclear Medicine Radioisotopes Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Positron Emission Tomography (PET) Nuclear Medicine Market 2024 - Product Thumbnail Image

Positron Emission Tomography (PET) Nuclear Medicine Market 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Nuclear Medicine Diagnostics Market Report 2025 - Product Thumbnail Image

Nuclear Medicine Diagnostics Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
Radiopharmaceutical Market - Product Thumbnail Image

Radiopharmaceutical Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
From
Loading Indicator

Fluorine-18 (F-18) is a radioactive isotope used in Nuclear Medicine and Radiopharmacy. It is produced in a cyclotron and is used in positron emission tomography (PET) imaging. F-18 is used to diagnose and monitor a variety of diseases, including cancer, heart disease, and neurological disorders. It is also used to measure the effectiveness of treatments. F-18 has a short half-life of 110 minutes, so it must be produced and used quickly. F-18 is used in a variety of radiopharmaceuticals, including Fluorodeoxyglucose (FDG), which is used to detect cancer. Other radiopharmaceuticals include Sodium Fluoride (NaF), which is used to detect bone metastases, and Fluoromisonidazole (FMISO), which is used to detect hypoxia. The F-18 market is highly competitive, with many companies offering radiopharmaceuticals and PET imaging services. Some of the major players in the market include GE Healthcare, Siemens Healthineers, Mallinckrodt Pharmaceuticals, and Jubilant DraxImage. Show Less Read more